234 filings
Page 4 of 12
CORRESP
rzg uxy5xz0496
3 Aug 09
Correspondence with SEC
12:00am
8-K
bpyqg31qw7lvl
28 Jul 09
Full-Year 2009 Revenue and Earnings Guidance Increased
12:00am
UPLOAD
lx0v28
24 Jul 09
Letter from SEC
12:00am
UPLOAD
6lubzfo15bq4i0xz
23 Jul 09
Letter from SEC
12:00am
8-K
n1d1ssh zcsk6l
24 Jun 09
Completion of Acquisition or Disposition of Assets
12:00am
D
s1b 1kb7nvz6jneeqg3l
9 Jun 09
Exempt offering of security
12:00am
8-K
4brykr6vutd65ms
3 Jun 09
Acquisition Will Add Unique Products and Technology to ev3 Neurovascular Franchise
12:00am
8-K
tgkqprv1w 8c
28 Apr 09
Constant Currency First Quarter Net Product Sales Increase 10% to $100.4 million
12:00am
ARS
lglg5cqbe96np
14 Apr 09
Annual report to shareholders
12:00am
DEFA14A
3x1gfx9bplf2439
13 Apr 09
Additional proxy soliciting materials
12:00am
8-K
2r5ps5f43y0wd4xgq9ej
7 Apr 09
Entry into a Material Definitive Agreement
12:00am
8-K
f6h7eysxo2jsim z2
24 Feb 09
Fourth Quarter Net Product Sales Increased 22% Over Fourth Quarter 2007
12:00am
8-K
nxcb zjwa5
20 Feb 09
Departure of Directors or Certain Officers
12:00am
8-K
icaom 9md5kqns2xy3a
6 Feb 09
Results of Operations and Financial Condition
12:00am
8-K
bly53sz6tsx0h1fvjs71
12 Jan 09
Regulation FD Disclosure
12:00am